A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma

A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma

BackgroundGlioma is a highly aggressive brain cancer with a poor prognosis. Necroptosis is a form of programmed cell death occurring during tumor development and in immune microenvironments. The prognostic value of necroptosis in glioma is unclear. This study aimed to develop a prognostic glioma mod...

Full description

Bibliographic Details
Main Authors:	Ying-Shi Yuan, Xin Jin, Lu Chen, Jia-Min Liao, Yang Zhang, Ke-Wei Yu, Wei-Kang Li, Shun-Wang Cao, Xian-Zhang Huang, Chun-Min Kang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Immunology
Subjects:	glioma necroptosis prognostic model immune infiltration immune checkpoint
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1027794/full

Similar Items

Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma
by: Zunjie Zhou, et al.
Published: (2022-06-01)

Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation
by: Yuying Huang, et al.
Published: (2024-03-01)

A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing
by: Kai Guo, et al.
Published: (2022-08-01)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
by: Cong Chen, et al.
Published: (2022-06-01)

A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma
by: Pengfei Xia, et al.
Published: (2022-08-01)

A novel necroptosis signature for predicting survival in lung adenocarcinoma
by: Kui Zang, et al.
Published: (2023-11-01)

Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
by: Desheng Chen, et al.
Published: (2022-08-01)

Necroptosis Related Genes Predict Prognosis and Therapeutic Potential in Gastric Cancer
by: Nandie Wu, et al.
Published: (2023-01-01)

Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
by: Ye Miao, et al.
Published: (2022-09-01)

Characterization of a lactate metabolism-related signature for evaluation of immune features and prediction prognosis in glioma
by: Zhiqiang Wu, et al.
Published: (2023-01-01)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
by: Hua Zhu, et al.
Published: (2022-07-01)

Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma
by: Shuxin Zhang, et al.
Published: (2022-11-01)

Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma
by: Xiqi Hu, et al.
Published: (2024-01-01)

Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma
by: Qiqi Tao, et al.
Published: (2023-10-01)

Role of necroptosis and immune infiltration in preeclampsia: novel insights from bioinformatics analyses
by: Lidan He, et al.
Published: (2023-07-01)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
by: Quanwei Zhou, et al.
Published: (2022-07-01)

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma
by: Jinna Li, et al.
Published: (2023-08-01)

Necroptosis-Related Genes Associated With Immune Activity and Prognosis of Colorectal Cancer
by: Xinyi Peng, et al.
Published: (2022-06-01)

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
by: Xiaoyue Ren, et al.
Published: (2023-08-01)

Characterizing the prognostic and therapeutic value of necroptosis in sarcoma based on necroptosis subtypes
by: Yibo Ma, et al.
Published: (2022-09-01)

Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma
by: Sicheng Wan, et al.
Published: (2022-11-01)

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
by: Renheng Zou, et al.
Published: (2023-05-01)

A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer
by: Wei-Peng He, et al.
Published: (2022-11-01)

A Novel Identified Necroptosis-Related Risk Signature for Prognosis Prediction and Immune Infiltration Indication in Acute Myeloid Leukemia Patients
by: Yong Sun, et al.
Published: (2022-10-01)

Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
by: Zhang Ming, et al.
Published: (2022-01-01)

Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes
by: Haoran Xie, et al.
Published: (2022-06-01)

Identification of a Necroptosis-Related Prognostic Index and Associated Regulatory Axis in Kidney Renal Clear Cell Carcinoma
by: Luo Y, et al.
Published: (2022-06-01)

Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma
by: Wenjuan Wang, et al.
Published: (2022-07-01)

Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma
by: Shaojian Lin, et al.
Published: (2020-10-01)

Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer
by: Zihan Zhao, et al.
Published: (2022-09-01)

Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer
by: Mengyu Sun, et al.
Published: (2022-12-01)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
by: Jun Tan, et al.
Published: (2021-03-01)

The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
by: Nan Zhang, et al.
Published: (2021-04-01)

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients
by: Shuai Ma, et al.
Published: (2023-06-01)

A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer
by: Zeyi Wang, et al.
Published: (2023-01-01)

Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
by: Tianyu Dong, et al.
Published: (2022-09-01)

Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
by: Hanwen Lu, et al.
Published: (2022-11-01)

Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages
by: Yuyang Liu, et al.
Published: (2022-03-01)

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
by: Hanwen Lu, et al.
Published: (2023-07-01)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
by: Kai Kang, et al.
Published: (2021-09-01)